The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nicotinamide Ribose (NR) Market Research Report 2024
Synopsis
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. The metabolism of NR is unique from that of other more commonly known forms of vitamin B3, nicotinamide and nicotinic acid. Specifically, NR has been shown in a pre-clinical study to be the most effective form of vitamin B3 at increasing nicotinamide adenine dinucleotide (NAD+)2.
The global Nicotinamide Ribose (NR) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. The metabolism of NR is unique from that of other more commonly known forms of vitamin B3, nicotinamide and nicotinic acid. Specifically, NR has been shown in a pre-clinical study to be the most effective form of vitamin B3 at increasing nicotinamide adenine dinucleotide (NAD+)2.
This report aims to provide a comprehensive presentation of the global market for Nicotinamide Ribose (NR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Ribose (NR).
Report Scope
The Nicotinamide Ribose (NR) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicotinamide Ribose (NR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicotinamide Ribose (NR) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chroma Dex
Elysium Health
Tru Niagen
Thorne
Zhejiang Jiahua Pharmchemical
Shenzhen Longgesheng Technology
Bontac Bio-engineering
Segment by Type
Pharmaceutical Grade
Food Grade
Other
Segment by Application
Dietary Supplement
Pharmaceutical Industry
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nicotinamide Ribose (NR) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nicotinamide Ribose (NR) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. The metabolism of NR is unique from that of other more commonly known forms of vitamin B3, nicotinamide and nicotinic acid. Specifically, NR has been shown in a pre-clinical study to be the most effective form of vitamin B3 at increasing nicotinamide adenine dinucleotide (NAD+)2.
The global Nicotinamide Ribose (NR) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. The metabolism of NR is unique from that of other more commonly known forms of vitamin B3, nicotinamide and nicotinic acid. Specifically, NR has been shown in a pre-clinical study to be the most effective form of vitamin B3 at increasing nicotinamide adenine dinucleotide (NAD+)2.
This report aims to provide a comprehensive presentation of the global market for Nicotinamide Ribose (NR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Ribose (NR).
Report Scope
The Nicotinamide Ribose (NR) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicotinamide Ribose (NR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicotinamide Ribose (NR) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chroma Dex
Elysium Health
Tru Niagen
Thorne
Zhejiang Jiahua Pharmchemical
Shenzhen Longgesheng Technology
Bontac Bio-engineering
Segment by Type
Pharmaceutical Grade
Food Grade
Other
Segment by Application
Dietary Supplement
Pharmaceutical Industry
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nicotinamide Ribose (NR) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nicotinamide Ribose (NR) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nicotinamide Ribose (NR) Market Overview
1.1 Product Overview and Scope of Nicotinamide Ribose (NR)
1.2 Nicotinamide Ribose (NR) Segment by Type
1.2.1 Global Nicotinamide Ribose (NR) Market Value Comparison by Type (2024-2030)
1.2.2 Pharmaceutical Grade
1.2.3 Food Grade
1.2.4 Other
1.3 Nicotinamide Ribose (NR) Segment by Application
1.3.1 Global Nicotinamide Ribose (NR) Market Value by Application: (2024-2030)
1.3.2 Dietary Supplement
1.3.3 Pharmaceutical Industry
1.3.4 Other
1.4 Global Nicotinamide Ribose (NR) Market Size Estimates and Forecasts
1.4.1 Global Nicotinamide Ribose (NR) Revenue 2019-2030
1.4.2 Global Nicotinamide Ribose (NR) Sales 2019-2030
1.4.3 Global Nicotinamide Ribose (NR) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nicotinamide Ribose (NR) Market Competition by Manufacturers
2.1 Global Nicotinamide Ribose (NR) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nicotinamide Ribose (NR) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nicotinamide Ribose (NR) Average Price by Manufacturers (2019-2024)
2.4 Global Nicotinamide Ribose (NR) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nicotinamide Ribose (NR), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nicotinamide Ribose (NR), Product Type & Application
2.7 Nicotinamide Ribose (NR) Market Competitive Situation and Trends
2.7.1 Nicotinamide Ribose (NR) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nicotinamide Ribose (NR) Players Market Share by Revenue
2.7.3 Global Nicotinamide Ribose (NR) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nicotinamide Ribose (NR) Retrospective Market Scenario by Region
3.1 Global Nicotinamide Ribose (NR) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nicotinamide Ribose (NR) Global Nicotinamide Ribose (NR) Sales by Region: 2019-2030
3.2.1 Global Nicotinamide Ribose (NR) Sales by Region: 2019-2024
3.2.2 Global Nicotinamide Ribose (NR) Sales by Region: 2025-2030
3.3 Global Nicotinamide Ribose (NR) Global Nicotinamide Ribose (NR) Revenue by Region: 2019-2030
3.3.1 Global Nicotinamide Ribose (NR) Revenue by Region: 2019-2024
3.3.2 Global Nicotinamide Ribose (NR) Revenue by Region: 2025-2030
3.4 North America Nicotinamide Ribose (NR) Market Facts & Figures by Country
3.4.1 North America Nicotinamide Ribose (NR) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nicotinamide Ribose (NR) Sales by Country (2019-2030)
3.4.3 North America Nicotinamide Ribose (NR) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nicotinamide Ribose (NR) Market Facts & Figures by Country
3.5.1 Europe Nicotinamide Ribose (NR) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nicotinamide Ribose (NR) Sales by Country (2019-2030)
3.5.3 Europe Nicotinamide Ribose (NR) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nicotinamide Ribose (NR) Market Facts & Figures by Country
3.6.1 Asia Pacific Nicotinamide Ribose (NR) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nicotinamide Ribose (NR) Sales by Country (2019-2030)
3.6.3 Asia Pacific Nicotinamide Ribose (NR) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nicotinamide Ribose (NR) Market Facts & Figures by Country
3.7.1 Latin America Nicotinamide Ribose (NR) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nicotinamide Ribose (NR) Sales by Country (2019-2030)
3.7.3 Latin America Nicotinamide Ribose (NR) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nicotinamide Ribose (NR) Market Facts & Figures by Country
3.8.1 Middle East and Africa Nicotinamide Ribose (NR) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nicotinamide Ribose (NR) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nicotinamide Ribose (NR) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nicotinamide Ribose (NR) Sales by Type (2019-2030)
4.1.1 Global Nicotinamide Ribose (NR) Sales by Type (2019-2024)
4.1.2 Global Nicotinamide Ribose (NR) Sales by Type (2025-2030)
4.1.3 Global Nicotinamide Ribose (NR) Sales Market Share by Type (2019-2030)
4.2 Global Nicotinamide Ribose (NR) Revenue by Type (2019-2030)
4.2.1 Global Nicotinamide Ribose (NR) Revenue by Type (2019-2024)
4.2.2 Global Nicotinamide Ribose (NR) Revenue by Type (2025-2030)
4.2.3 Global Nicotinamide Ribose (NR) Revenue Market Share by Type (2019-2030)
4.3 Global Nicotinamide Ribose (NR) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nicotinamide Ribose (NR) Sales by Application (2019-2030)
5.1.1 Global Nicotinamide Ribose (NR) Sales by Application (2019-2024)
5.1.2 Global Nicotinamide Ribose (NR) Sales by Application (2025-2030)
5.1.3 Global Nicotinamide Ribose (NR) Sales Market Share by Application (2019-2030)
5.2 Global Nicotinamide Ribose (NR) Revenue by Application (2019-2030)
5.2.1 Global Nicotinamide Ribose (NR) Revenue by Application (2019-2024)
5.2.2 Global Nicotinamide Ribose (NR) Revenue by Application (2025-2030)
5.2.3 Global Nicotinamide Ribose (NR) Revenue Market Share by Application (2019-2030)
5.3 Global Nicotinamide Ribose (NR) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Chroma Dex
6.1.1 Chroma Dex Corporation Information
6.1.2 Chroma Dex Description and Business Overview
6.1.3 Chroma Dex Nicotinamide Ribose (NR) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Chroma Dex Nicotinamide Ribose (NR) Product Portfolio
6.1.5 Chroma Dex Recent Developments/Updates
6.2 Elysium Health
6.2.1 Elysium Health Corporation Information
6.2.2 Elysium Health Description and Business Overview
6.2.3 Elysium Health Nicotinamide Ribose (NR) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Elysium Health Nicotinamide Ribose (NR) Product Portfolio
6.2.5 Elysium Health Recent Developments/Updates
6.3 Tru Niagen
6.3.1 Tru Niagen Corporation Information
6.3.2 Tru Niagen Description and Business Overview
6.3.3 Tru Niagen Nicotinamide Ribose (NR) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Tru Niagen Nicotinamide Ribose (NR) Product Portfolio
6.3.5 Tru Niagen Recent Developments/Updates
6.4 Thorne
6.4.1 Thorne Corporation Information
6.4.2 Thorne Description and Business Overview
6.4.3 Thorne Nicotinamide Ribose (NR) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Thorne Nicotinamide Ribose (NR) Product Portfolio
6.4.5 Thorne Recent Developments/Updates
6.5 Zhejiang Jiahua Pharmchemical
6.5.1 Zhejiang Jiahua Pharmchemical Corporation Information
6.5.2 Zhejiang Jiahua Pharmchemical Description and Business Overview
6.5.3 Zhejiang Jiahua Pharmchemical Nicotinamide Ribose (NR) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhejiang Jiahua Pharmchemical Nicotinamide Ribose (NR) Product Portfolio
6.5.5 Zhejiang Jiahua Pharmchemical Recent Developments/Updates
6.6 Shenzhen Longgesheng Technology
6.6.1 Shenzhen Longgesheng Technology Corporation Information
6.6.2 Shenzhen Longgesheng Technology Description and Business Overview
6.6.3 Shenzhen Longgesheng Technology Nicotinamide Ribose (NR) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shenzhen Longgesheng Technology Nicotinamide Ribose (NR) Product Portfolio
6.6.5 Shenzhen Longgesheng Technology Recent Developments/Updates
6.7 Bontac Bio-engineering
6.6.1 Bontac Bio-engineering Corporation Information
6.6.2 Bontac Bio-engineering Description and Business Overview
6.6.3 Bontac Bio-engineering Nicotinamide Ribose (NR) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bontac Bio-engineering Nicotinamide Ribose (NR) Product Portfolio
6.7.5 Bontac Bio-engineering Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nicotinamide Ribose (NR) Industry Chain Analysis
7.2 Nicotinamide Ribose (NR) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nicotinamide Ribose (NR) Production Mode & Process
7.4 Nicotinamide Ribose (NR) Sales and Marketing
7.4.1 Nicotinamide Ribose (NR) Sales Channels
7.4.2 Nicotinamide Ribose (NR) Distributors
7.5 Nicotinamide Ribose (NR) Customers
8 Nicotinamide Ribose (NR) Market Dynamics
8.1 Nicotinamide Ribose (NR) Industry Trends
8.2 Nicotinamide Ribose (NR) Market Drivers
8.3 Nicotinamide Ribose (NR) Market Challenges
8.4 Nicotinamide Ribose (NR) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
